產品詳情
簡單介紹：
Anti-PCDHGA7抗體產品質量穩定，實驗效果明顯，貨期快，價格優惠，歡迎垂詢訂購！我公司長期供應**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關試劑、熒光標記抗體、單克隆抗體、多克隆抗體、各種標記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-PCDHGA7抗體用于**組化實驗,WB實驗,相應的標記抗體有HRP標記抗體,FITC標記,BIO等。
詳情介紹：
Rabbit Anti-PCDHGA7
Cat. Number:
Anti-PCDHGA7抗體KL-11148R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Protocadherins are a large family of cadherin-like cell adhesion proteins that are involved in the establishment and maintenance of neuronal connections in the brain. There are three protocadherin (PCDH) gene clusters,Anti-PCDHGA7抗體 designated alpha, beta and gamma, all of which contain multiple tandemly arranged genes. PCDHGA7 (Protocadherin gamma-A7) is a 932 amino acid that is one of 22 proteins encoded by the protocadherin gamma cluster. The protocadherein gamma cluster consists of three subfamilies (A, B and C) and PCDHGA7 is a member of the gamma subfamily A. PCDHGA7 is a type I transmembrane receptor containing six cadherin motifs and is expressed in the central nervous system where it localizes to synapses. Members of the gamma cluster of protocadherins are essential for neuronal survival. There are two isoforms of PCDHGA7 that are produced as a result of alternative splicing events.
Also known as:
PCDG7_HUMAN; PCDH-gamma-A7;Anti-PCDHGA7抗體 PCDHGA7; protocadherin gamma subfamily A, 7; Protocadherin gamma-A7.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, .
●
Immunogen: KLH conjugated syntheticAnti-PCDHGA7抗體 peptide derived from human PCDHGA7.
●
Predicted Molecular Weight: 99kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications. Anti-PCDHGA7抗體
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications. Anti-PCDHGA7抗體
Optimal working dilutions must be determined by the end user.
